Analysis of Class II MHC and CD1d antigen presentation pathways in skin-derived d

皮肤源性d中II类MHC和CD1d抗原呈递途径分析

基本信息

  • 批准号:
    7365095
  • 负责人:
  • 金额:
    $ 20.86万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-03-01 至 2012-02-29
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Dendritic cells (DCs) are sentinels of the peripheral immune system that continuously survey their surroundings for pathogens, by fluid phase uptake and endocytosis. When pathogen-derived fragments are detected, DCs engulf the foreign material and in the process become activated. Engulfed proteins are processed and displayed as peptide/MHC complexes to Class II MHC-restricted T cells, while lipids are incorporated into CD1/(32m/lipid complexes for presentation to CD1-restricted T cells. Much of what is known about endosomal antigen processing, loading and presentation of Class II MHC molecules was learned through biochemical and cell biological analysis of B cell lines, and to a more limited extent, of cultured DCs. New methodology now makes it possible to visualize the uptake of red fluorescent antigen by live Class II MHC-positive DCs in situ in the epidermis of mice that express green fluorescent protein (GFP)-Class II MHC fusion proteins. Trafficking of antigen-experienced DCs to skin-draining lymph nodes can be tracked in live cells. First, we will study the protein and lipid antigen-presentation pathways in skin-derived DCs and lymph node-resident DCs. We will test our hypothesis that during inflammation, priming of immune responses in the skin requires cell-mediated transport of both protein and lipid antigens by epidermis- resident DCs (Langerhans cells) to skin-draining lymph nodes. Antigen presentation by DCs that reside in the T cell area of lymph nodes is essential for T cell priming. We hypothesize that antigen transfer from LC to a non-migratory lymph node-resident DCs is necessary for successful T cell priming to occur. Accordingly, mutant mice in which LCs express normal antigen endocytosis but defective endosomal processing should have limited phenotype. In contrast, mice expressing non-migratory DCs defective in endosomal processing should exhibit reduced T cell priming capacities. We will study antigen processing and Class II MHC presentation pathways in epidermis-derived Langerhans cells and lymph node-resident DC subtypes. Finally, we have succeeded to generate a new mouse model to study CD1-mediated antigen presentation in vivo. The possible involvement of CD1d to immune responses originating in the skin will be investigated in CD1d- yellow fluorescent protein knock-in mice.
描述(由申请人提供):树突状细胞(DC)是外周免疫系统的哨兵,通过液相摄取和内吞作用不断地调查周围环境中的病原体。当检测到病原体衍生的片段时,树突状细胞会吞噬异物并在此过程中被激活。吞噬的蛋白质被加工并以肽/MHC复合物的形式展示给II类MHC限制性T细胞,而脂质则被整合到CD1/(32m/脂质复合物中以呈递给CD1限制性T细胞。关于内体抗原加工、II类MHC分子的装载和呈递的大部分知识是通过B细胞系的生化和细胞生物学分析得知的, 以及在更有限的范围内培养的 DC。现在,新的方法可以使表达绿色荧光蛋白 (GFP)-II 类 MHC 融合蛋白的小鼠表皮中的活 II 类 MHC 阳性 DC 对红色荧光抗原的摄取进行可视化。可以追踪经历过抗原的 DC 向皮肤引流淋巴结的贩运 活细胞。首先,我们将研究皮肤源性 DC 和淋巴结驻留 DC 中的蛋白质和脂质抗原呈递途径。我们将检验我们的假设,即在炎症期间,皮肤免疫反应的启动需要表皮驻留 DC(朗格汉斯细胞)通过细胞介导的方式将蛋白质和脂质抗原转运至皮肤引流淋巴结。 位于淋巴结 T 细胞区域的 DC 呈递抗原对于 T 细胞启动至关重要。我们假设抗原从 LC 转移到非迁移性淋巴结驻留 DC 是 T 细胞成功启动所必需的。因此,LC表达正常抗原内吞作用但内体加工有缺陷的突变小鼠应具有有限的表型。相比之下,小鼠 表达内体加工缺陷的非迁移 DC 应该表现出 T 细胞启动能力降低。我们将研究表皮衍生朗格汉斯细胞和淋巴结驻留 DC 亚型中的抗原加工和 II 类 MHC 呈递途径。最后,我们成功地建立了一种新的小鼠模型来研究 CD1 介导的体内抗原呈递。 CD1d 可能参与 将在 CD1d-黄色荧光蛋白敲入小鼠中研究对源自皮肤的免疫反应的影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT C FUHLBRIGGE其他文献

ROBERT C FUHLBRIGGE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT C FUHLBRIGGE', 18)}}的其他基金

Influence of Chemokine Receptors on T Cell Cytokine Profiles in Skin
趋化因子受体对皮肤 T 细胞细胞因子谱的影响
  • 批准号:
    8424943
  • 财政年份:
    2012
  • 资助金额:
    $ 20.86万
  • 项目类别:
Leukocyte Migration
白细胞迁移
  • 批准号:
    7681110
  • 财政年份:
    2008
  • 资助金额:
    $ 20.86万
  • 项目类别:
Leukocyte Migration
白细胞迁移
  • 批准号:
    7393284
  • 财政年份:
    2007
  • 资助金额:
    $ 20.86万
  • 项目类别:
Analysis of Class II MHC and CD1d antigen presentation pathways in skin-derived d
皮肤源性d中II类MHC和CD1d抗原呈递途径分析
  • 批准号:
    8035374
  • 财政年份:
    2007
  • 资助金额:
    $ 20.86万
  • 项目类别:
Analysis of Class II MHC and CD1d antigen presentation pathways in skin-derived d
皮肤源性d中II类MHC和CD1d抗原呈递途径分析
  • 批准号:
    7770808
  • 财政年份:
    2007
  • 资助金额:
    $ 20.86万
  • 项目类别:
Analysis of Class II MHC and CD1d antigen presentation pathways in skin-derived d
皮肤源性d中II类MHC和CD1d抗原呈递途径分析
  • 批准号:
    7574364
  • 财政年份:
    2007
  • 资助金额:
    $ 20.86万
  • 项目类别:
CORE--Leukocyte Migration
核心--白细胞迁移
  • 批准号:
    6756257
  • 财政年份:
    2004
  • 资助金额:
    $ 20.86万
  • 项目类别:
Structure Function Analysis of T Cell E-Selectin Ligands
T细胞E-选择素配体的结构功能分析
  • 批准号:
    7004531
  • 财政年份:
    2003
  • 资助金额:
    $ 20.86万
  • 项目类别:
Structure Function Analysis of T Cell E-Selectin Ligands
T细胞E-选择素配体的结构功能分析
  • 批准号:
    7159324
  • 财政年份:
    2003
  • 资助金额:
    $ 20.86万
  • 项目类别:
Structure Function Analysis of T Cell E-Selectin Ligands
T细胞E-选择素配体的结构功能分析
  • 批准号:
    6671720
  • 财政年份:
    2003
  • 资助金额:
    $ 20.86万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 20.86万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 20.86万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 20.86万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 20.86万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 20.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 20.86万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 20.86万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 20.86万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 20.86万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 20.86万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了